TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
| Market size in 2024 | US$ 156.3 million |
Forecast Market size by 2030 | US$ 204.8 million |
|---|---|---|---|
| Growth Rate | CAGR of 4.6% | Number of Pages | 205 Pages |
The Asia Pacific Tranexamic Acid market size was valued at US$ 156.3 million in 2024 and is projected to reach US$ 204.8 million by 2030, at a CAGR of 4.6% during the forecast period 2024-2030.
Tranexamic acid is a synthetic amino acid derivative used as an antifibrinolytic medication to treat or prevent excessive blood loss in various medical conditions and surgical procedures.
The Asia Pacific tranexamic acid market is growing steadily, driven by increasing surgical procedures and awareness of its effectiveness in managing bleeding disorders. Japan leads with a 30% market share, followed by China at 25% and India at 20%. In 2023, surgical applications accounted for 55% of total consumption, with gynecological uses at 25% and trauma management at 15%. The market experienced a 7% growth in demand from the cosmetic industry for skin whitening applications. Key players include Daiichi Sankyo (Japan) and Emcure Pharmaceuticals (India), holding a combined 35% market share in the region. The industry is investing in novel formulations, with a 12% increase in R&D spending on extended-release preparations in 2023. Challenges include patent expirations, leading to a 15% increase in generic competition. The COVID-19 pandemic has driven a 10% rise in demand for managing complications in severe cases. The market is benefiting from expanding healthcare access in developing countries, with an 8% growth in rural healthcare initiatives incorporating tranexamic acid in emergency kits.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Tranexamic Acid . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Tranexamic Acid , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Tranexamic Acid , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid . This report contains market size and forecasts of Tranexamic Acid in Asia Pacific, including the following market information:
We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
• China
• India
• Japan
• South Korea
• Australia
• Thailand
• Indonesia
• USP25
• BP2000
• Other
• Trauma
• Craniocerebral Trauma
• Menorrhagia
• Postpartum Hemorrhage
• Surgery
• Other Treatment
• Whitening Cosmetics
• Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd.
• Shanxi Kangbao Biological Product Co., Ltd
• Nippon Pharmaceutical Co., Ltd
• Hikma Pharmaceuticals PLC
• Olon S.p.A.
• Zhejiang Huayi Pharmaceutical Co., Ltd.
• Sanghai Lonyer Fuels Co., Ltd
• Zydus Cadila
• Emcure Pharmaceuticals Ltd.
• Micro Labs Ltd
Including or excluding key companies relevant to your analysis.
The report also provides analysis of leading market participants including:
• Key companies Tranexamic Acid revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)
• Key companies Tranexamic Acid revenues share in Asia Pacific market, 2023 (%)
• Key companies Tranexamic Acid sales in Asia Pacific market, 2019-2024 (Estimated),
• Key companies Tranexamic Acid sales share in Asia Pacific market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Asia Pacific and country-wise market of Tranexamic Acid
• It describes present situation, historical background and future forecast
• Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Tranexamic Acid manufacturers
• Tranexamic Acid forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
| Report Attributes | Report Details |
|---|---|
| Report Title | Asia Pacific Tranexamic Acid Market Research Report 2024-2030 |
| Market size in 2024 | US$ 156.3 million |
| Forecast Market size by 2030 | US$ 204.8 million |
| Growth Rate | CAGR of 4.6% |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2023 |
| Forecast Year | 2031 |
| Number of Pages | 205 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
1.1 Product Overview and Scope of Tranexamic Acid
1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 USP25
1.2.3 BP2000
1.2.4 Other
1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Trauma
1.3.3 Craniocerebral Trauma
1.3.4 Menorrhagia
1.3.5 Postpartum Hemorrhage
1.3.6 Surgery
1.3.7 Other Treatment
1.3.8 Whitening Cosmetics
1.4 Asia Pacific Market Growth Prospects
1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)
1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Asia Pacific Production by Manufacturers (2019-2023)
3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Asia Pacific Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Asia Pacific Production
4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)
4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Asia Pacific
5.1.1 Asia Pacific Consumption by Country
5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)
5.1.1 China
5.2.2 India
5.3.3 Japan
5.4.4 South Korea
5.5.5 Australia
5.6.6 Thailand
5.7.7 Indonesia
6.1 Asia Pacific Production Market Share by Type (2019-2024)
6.2 Asia Pacific Revenue Market Share by Type (2019-2024)
6.3 Asia Pacific Price by Type (2019-2024)
7.1 Asia Pacific Production Market Share by Application (2019-2024)
7.2 Asia Pacific Revenue Market Share by Application (2019-2024)
7.3 Asia Pacific Price by Application (2019-2024)
8.1 Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd.
8.1.1 Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd. Corporation Information
8.1.2 Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd. Product Portfolio
8.1.3 Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd. Main Business and Markets Served
8.1.5 Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
8.2 Shanxi Kangbao Biological Product Co., Ltd
8.2.1 Shanxi Kangbao Biological Product Co., Ltd Corporation Information
8.2.2 Shanxi Kangbao Biological Product Co., Ltd Product Portfolio
8.2.3 Shanxi Kangbao Biological Product Co., Ltd Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Shanxi Kangbao Biological Product Co., Ltd Main Business and Markets Served
8.2.5 Shanxi Kangbao Biological Product Co., Ltd Recent Developments/Updates
8.3 Nippon Pharmaceutical Co., Ltd
8.3.1 Nippon Pharmaceutical Co., Ltd Corporation Information
8.3.2 Nippon Pharmaceutical Co., Ltd Product Portfolio
8.3.3 Nippon Pharmaceutical Co., Ltd Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Nippon Pharmaceutical Co., Ltd Main Business and Markets Served
8.3.5 Nippon Pharmaceutical Co., Ltd Recent Developments/Updates
8.4 Hikma Pharmaceuticals PLC
8.4.1 Hikma Pharmaceuticals PLC Corporation Information
8.4.2 Hikma Pharmaceuticals PLC Product Portfolio
8.4.3 Hikma Pharmaceuticals PLC Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Hikma Pharmaceuticals PLC Main Business and Markets Served
8.4.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
8.5 Olon S.p.A.
8.5.1 Olon S.p.A. Corporation Information
8.5.2 Olon S.p.A. Product Portfolio
8.5.3 Olon S.p.A. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Olon S.p.A. Main Business and Markets Served
8.5.5 Olon S.p.A. Recent Developments/Updates
8.6 Zhejiang Huayi Pharmaceutical Co., Ltd.
8.6.1 Zhejiang Huayi Pharmaceutical Co., Ltd. Corporation Information
8.6.2 Zhejiang Huayi Pharmaceutical Co., Ltd. Product Portfolio
8.6.3 Zhejiang Huayi Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Zhejiang Huayi Pharmaceutical Co., Ltd. Main Business and Markets Served
8.6.5 Zhejiang Huayi Pharmaceutical Co., Ltd. Recent Developments/Updates
8.7 Sanghai Lonyer Fuels Co., Ltd
8.7.1 Sanghai Lonyer Fuels Co., Ltd Corporation Information
8.7.2 Sanghai Lonyer Fuels Co., Ltd Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Sanghai Lonyer Fuels Co., Ltd Main Business and Markets Served
8.7.4 Sanghai Lonyer Fuels Co., Ltd Recent Developments/Updates
8.8 Zydus Cadila
8.8.1 Zydus Cadila Corporation Information
8.8.2 Zydus Cadila Product Portfolio
8.8.3 Zydus Cadila Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Zydus Cadila Main Business and Markets Served
8.8.5 Zydus Cadila Recent Developments/Updates
8.9 Emcure Pharmaceuticals Ltd.
8.9.1 Emcure Pharmaceuticals Ltd. Corporation Information
8.9.2 Emcure Pharmaceuticals Ltd. Product Portfolio
8.9.3 Emcure Pharmaceuticals Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Emcure Pharmaceuticals Ltd. Main Business and Markets Served
8.9.5 Emcure Pharmaceuticals Ltd. Recent Developments/Updates
8.10 Micro Labs Ltd
8.10.1 Micro Labs Ltd Corporation Information
8.10.2 Micro Labs Ltd Product Portfolio
8.10.3 Micro Labs Ltd Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Micro Labs Ltd Main Business and Markets Served
8.10.5 Micro Labs Ltd Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Tranexamic Acid
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Asia Pacific Production, Revenue Forecast (2024-2030)
13.1 Asia Pacific Forecasted Consumption of by Country
14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)
14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)
14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)
14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)
14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)
14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
